Skip to main content

atomoxetine

NDC 50090-7342 · A-S Medication Solutions

Generic nameatomoxetine
Dosage formCAPSULE
RouteORAL
Active ingredient(s)ATOMOXETINE HYDROCHLORIDE
Strength25 mg/1
Pharmacologic classNorepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
Marketing categoryANDA

Packages

50090-7342-0 — 30 CAPSULE in 1 BOTTLE (50090-7342-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6127 — Atomoxetine, 50090-6143 — Atomoxetine, 50090-6144 — Atomoxetine, 50090-6254 — Atomoxetine, 50090-6289 — Atomoxetine, 50090-6444 — Atomoxetine, 50090-6511 — Atomoxetine, 50090-6512 — Atomoxetine, 50090-6513 — Atomoxetine, 50090-6703 — Atomoxetine, 50090-7397 — atomoxetine, 50090-7462 — atomoxetine, 50090-7463 — atomoxetine, 50268-057 — atomoxetine hydrochloride, 50268-058 — atomoxetine hydrochloride, 50268-059 — atomoxetine hydrochloride, 51407-100 — atomoxetine hydrochloride, 51407-101 — atomoxetine hydrochloride, 51407-102 — atomoxetine hydrochloride, 51407-103 — atomoxetine hydrochloride, +116 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels